Meeting of the National Advisory Council for Healthcare Research and Quality, 61000 [2012-24455]

Download as PDF 61000 Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: September 27, 2012. Carolyn M. Clancy, Director. [FR Doc. 2012–24454 Filed 10–4–12; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Friday, November 9, 2012, from 8:30 a.m. to 3:30 p.m. ADDRESSES: The meeting will be held at the Eisenberg Conference Center, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland 20850. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Coordinator of the Advisory Council, at the Agency for Healthcare Research and Quality, 540 pmangrum on DSK3VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:25 Oct 04, 2012 Jkt 229001 Gaither Road, Rockville, Maryland 20850, (301) 427–1456. For press-related information, please contact Alison Hunt at (301) 427–1244. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Friday, October 26, 2012. The agenda, roster, and minutes are available from Ms. Bonnie Campbell, Committee Management Officer, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland 20850. Ms. Campbell’s phone number is (301) 427–1554. SUPPLEMENTARY INFORMATION: I. Purpose The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director, Agency for Healthcare Research and Quality (AHRQ), on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Friday, November 9, 2012, there will be a subcommittee meeting for the National Healthcare Quality and Disparities Report scheduled to begin at 7:30 a.m. The Council meeting will convene at 8:30 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting will begin with a report from the National Advisory Council Subcommittee on the Children’s Health Insurance Program Reauthorization Act. The AHRQ Director will then present her update on current research, programs, and initiatives. Following the morning session, the Council will hold an Executive Session between the hours of 12:00 p.m. and 1:30 p.m. to discuss strategic issues related to the Agency for Healthcare Research and Quality. This Executive Session will be closed to the PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 public in accordance with 5 U.S.C. App. 2, section 10(d) and 5 U.S.C. 552b(c)(9)(B). This portion of the meeting is likely to disclose information the premature disclosure of which would be likely to significantly frustrate implementation of a proposed agency action to the public. The final agenda will be available on the AHRQ Web site at www.AHRQ.gov no later than Friday, November 2, 2012. Dated: September 27, 2012. Carolyn M. Clancy, Director. [FR Doc. 2012–24455 Filed 10–4–12; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 10 a.m.–12:15 p.m. EDT, October 24, 2012. Place: Teleconference. Status: Open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment period. A public comment period is tentatively scheduled for 12 p.m. to 12:15 p.m. To participate in the teleconference, please dial (866) 561– 5277 and enter code 2238494. Purpose: The Subcommittee will provide advice to the CDC Director through the ACD on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC. Matters to be discussed: Agenda items will include the following: Office of Minority Health and Health Equity updates; discussion of draft recommendations from April 2012 meeting with the IOM Health Disparities Roundtable; discussion of Critical issues and Recommendations (Strategies to Strengthen CDC Response to Social Determinants of Health and Inequities); discussion regarding organizing the workflow of the HDS going forward; and HDS membership after June 2013. The agenda is subject to change as priorities dictate. E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 77, Number 194 (Friday, October 5, 2012)]
[Notices]
[Page 61000]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24455]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a) of the Federal Advisory 
Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the 
National Advisory Council for Healthcare Research and Quality.

DATES: The meeting will be held on Friday, November 9, 2012, from 8:30 
a.m. to 3:30 p.m.

ADDRESSES: The meeting will be held at the Eisenberg Conference Center, 
Agency for Healthcare Research and Quality, 540 Gaither Road, 
Rockville, Maryland 20850.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Coordinator of the 
Advisory Council, at the Agency for Healthcare Research and Quality, 
540 Gaither Road, Rockville, Maryland 20850, (301) 427-1456. For press-
related information, please contact Alison Hunt at (301) 427-1244.
    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact the Food and Drug 
Administration (FDA) Office of Equal Employment Opportunity and 
Diversity Management on (301) 827-4840, no later than Friday, October 
26, 2012. The agenda, roster, and minutes are available from Ms. Bonnie 
Campbell, Committee Management Officer, Agency for Healthcare Research 
and Quality, 540 Gaither Road, Rockville, Maryland 20850. Ms. 
Campbell's phone number is (301) 427-1554.

SUPPLEMENTARY INFORMATION: 

I. Purpose

    The National Advisory Council for Healthcare Research and Quality 
is authorized by Section 941 of the Public Health Service Act, 42 
U.S.C. 299c. In accordance with its statutory mandate, the Council is 
to advise the Secretary of the Department of Health and Human Services 
and the Director, Agency for Healthcare Research and Quality (AHRQ), on 
matters related to AHRQ's conduct of its mission including providing 
guidance on (A) priorities for health care research, (B) the field of 
health care research including training needs and information 
dissemination on health care quality and (C) the role of the Agency in 
light of private sector activity and opportunities for public private 
partnerships.
    The Council is composed of members of the public, appointed by the 
Secretary, and Federal ex-officio members specified in the authorizing 
legislation.

II. Agenda

    On Friday, November 9, 2012, there will be a subcommittee meeting 
for the National Healthcare Quality and Disparities Report scheduled to 
begin at 7:30 a.m. The Council meeting will convene at 8:30 a.m., with 
the call to order by the Council Chair and approval of previous Council 
summary notes. The meeting will begin with a report from the National 
Advisory Council Subcommittee on the Children's Health Insurance 
Program Reauthorization Act. The AHRQ Director will then present her 
update on current research, programs, and initiatives. Following the 
morning session, the Council will hold an Executive Session between the 
hours of 12:00 p.m. and 1:30 p.m. to discuss strategic issues related 
to the Agency for Healthcare Research and Quality. This Executive 
Session will be closed to the public in accordance with 5 U.S.C. App. 
2, section 10(d) and 5 U.S.C. 552b(c)(9)(B). This portion of the 
meeting is likely to disclose information the premature disclosure of 
which would be likely to significantly frustrate implementation of a 
proposed agency action to the public. The final agenda will be 
available on the AHRQ Web site at www.AHRQ.gov no later than Friday, 
November 2, 2012.

    Dated: September 27, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-24455 Filed 10-4-12; 8:45 am]
BILLING CODE 4160-90-M